In Vivo CAR T-Cell Therapy Spurs 100% ORR in Phase I

Cancer Discovery · Published 2026-06-09 · DOI 10.1158/2159-8290.cd-nw2026-0067

Authors being retrieved — see the publisher record. https://doi.org/10.1158/2159-8290.cd-nw2026-0067

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Spatial multi-omics implicate the interaction between Tpex and B cells in tertiary lymphoid structures after neoadjuvant therapy · Cancer Discovery · 2026 · Same journal
• PROTEUS May Mean New SOC for Some Prostate Cancers · Cancer Discovery · 2026 · Same journal
• Acquisition of Centromeric Features Supports Telomere Integrity · Cancer Discovery · 2026 · Same journal
• mtDNA Lineage Tracing Reveals Monocyte Fate Bias Prior to Tumor Infiltration · Cancer Discovery · 2026 · Same journal
• Highlighted Research Articles · Cancer Discovery · 2026 · Same journal
• Systematic Targeting of Protein Complexes with Molecular COUPLrs · Cancer Discovery · 2026 · Same journal
• The Promise of Machine Learning–Based Population Screening for Hepatocellular Carcinoma · Cancer Discovery · 2026 · Same journal
• Q&A: Timothy Yap on Clinical Trials and Drug Development · Cancer Discovery · 2026 · Same journal
• Genomics of Subsequent Neoplasms in Childhood Cancer Survivors · Cancer Discovery · 2026 · Same journal
• AKR1C1 Promotes ADC Resistance by Altering Uptake and Export · Cancer Discovery · 2026 · Same journal